Corporate governance

Our governance structure

Board of Directors policy

The overall task of the Board is to manage the affairs of the Company in the best possible manner on behalf of the shareholders. The Board must continuously evaluate the Group’s operations, development and financial situation, as well as the operative management.

Details regarding the Board of Director’s activities and responsibilities can be found in the latest Annual Report. The Board works according to rules of procedure which are adopted annually and govern the frequency and agenda of board meetings, distribution of materials for meetings, and matters to be presented to the Board for information or for a decision. Additionally, the rules of procedure govern how the board work is allocated among the Board and its committees. The Board has also adopted CEO instructions which govern the allocation of work among the Board, the Chairman, and the CEO, and which defines the CEO’s authority.

Pursuant to the Swedish Corporate Governance Code, the Board of Directors is to evaluate its work annually, using a systematic and structured process, with the aim of developing the Board’s working methods and efficiency.

Evaluation of Board of Directors work

Pursuant to the Swedish Corporate Governance Code, the Board is to evaluate its work annually, using a systematic and structured process, with the aim of developing the Board’s working methods and efficiency.

Management share transactions

According to applicable insider legislation, members of the Hansa Biopharma board and members of group management must report transactions in financial instruments related to Hansa Biopharma to the Swedish Financial Supervisory Authority. See information on board members and group management members' shareholdings in Our leadership. For transactions, refer to the Swedish Financial Supervisory Authority via the following link:

Transaction overview